Marella Thorell - Sep 1, 2022 Form 4 Insider Report for Evelo Biosciences, Inc. (EVLO)

Role
Chief Financial Officer
Signature
/s/ Daniel S. Char, Attorney-in-Fact for Marella Thorell
Stock symbol
EVLO
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/1/2022, 04:52 PM
Previous filing
Jul 18, 2022
Next filing
Dec 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +440K $0.00 440K Sep 1, 2022 Common Stock 440K $2.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the underlying shares will vest on the first anniversary of the reporting person's employment commencement date (i.e., September 1, 2023), and the remaining 75% of the underlying shares will vest in 36 substantially equal monthly installments thereafter